News
-
Dispensary Corner 10 Mar 17
Friday | Mar 10 2017THE small Canadian town of Onoway in Alberta was in the pink - literally - recently, with residents finding coloured water coming from their taps.
-
Leaders line up at APP2017
Friday | Mar 10 2017YESTERDAY'S State of the Industry Symposium at the APP conference saw leaders of key Australian medicines organisations give an overview of the current situation in each of their sectors.
-
Walker walks away with POTY
Friday | Mar 10 2017LUCY Walker Chemmart Pharmacy from Goondiwindi in regional Queensland was yesterday named the overall winner of the 2017 Guild Pharmacy of the Year award, with health minister Greg Hunt making the announcement at APP (PD breaking news).
-
Afluria Quad available
Friday | Mar 10 2017AUSTRALIA'S only locally manufactured influenza vaccine is now available for the private market, as well as being listed on the National Immunisation Program for the 2017 flu season (PD 07 Mar).
-
GuildCare NG partners with KnowITall
Friday | Mar 10 2017PHARMACY loyalty and marketing company, KnowITall and the Pharmacy Guild of Australia's professional services software provider GuildLink's GuildCare NG, have announced a collaboration integrating the two platforms.
-
Hunt pharmacy praise
Friday | Mar 10 2017THE Pharmacy Guild welcomed comments made by Health Minister Greg Hunt during his presentation opening APP yesterday, with Guild President George Tambassis saying it was the "best speech I have heard in the last three years".
-
Apotex buys Reform vaccine portal
Friday | Mar 10 2017APOTEX late yesterday announced the acquisition of the online vaccine portal operated by Peter Nelson's Reform Management (PD breaking news).
-
Placebo alert
Friday | Mar 10 2017THE Therapeutic Goods Administration has issued a formal warning about Placebo Tablets (pictured) which it has found contain the undeclared prescription-only substance clenbuterol.
-
CSO unsustainable – Hooper
Friday | Mar 10 2017AUSTRALIA'S full-line pharmacy wholesalers may be forced to begin charging for some deliveries, unless significant changes are made to the funding of the country's pharmaceutical supply chain.